Furthermore, the results of the immunofluorescence assays in PDOs demonstrated that the expression of cancer stem cell markers, such as CD133 and β-catenin, was decreased when cells were transfected with Sh-KMT2D (Fig. 2D, Additional file 1: Fig. S1C). The gene discussed is KMT2D; the disease is cancer.